Andere talen Hunan Warrant Pharmaceutical Co.,Ltd

Aandelen

688799

CNE100004P73

slotkoers Shanghai S.E. Andere beurzen 00:00:00 17-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
42 ^CNY	-4,11%		-7,79%	-14,18%

19/04	Hunan Warrant Pharmaceutical Co.,Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
25/02	Hunan Warrant Pharmaceutical Co.,Ltd rapporteert resultaten voor het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	25/02
Warrant Pharmaceutical's Diclofenac Tablets Passes Regulatory Evaluation	21/12
Hunan Warrant Pharma Passes GMP Compliance Inspection	14/11
Warrant Pharmaceutical's Heart Disease Medication Passes Generic Drug Evaluation in China	02/11
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	29-10-23
Warrant Pharmaceutical Gets Nod to Market Clopidogrel Bisulfate	23-10-23
Zhuhai Qianlie Pharmaceutical Co., Ltd. announced that it expects to receive CNY 25 million in funding from Hunan Warrant Pharmaceutical Co.,Ltd	16-10-23
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	27-08-23
Warrant Pharma Unit Registers Arthritis Drug in South Korea	12-07-23
Warrant Pharma Secures Product Registration Certificate in South Korea	22-05-23
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	29-04-23
Warrant Pharma Gets Regulatory Green Light to Issue Bonds	26-04-23
Warrant Pharma Gets Registration Certificate in China for Asthma Drug	27-03-23
Hunan Warrant Pharma Posts 12.2% Rise in 2022 Profit	24-02-23
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	22-02-23
Hunan Warrant Pharma's Drug Production Base Passes Regulator's GMP Inspection	09-02-23
Hunan Warrant Pharma’s Hepatitis Drug Included in China’s Medical Insurance Catalog	19-01-23
Hunan Warrant Pharma to Raise 691 Million Yuan For New Production Base	13-12-22
Hunan Warrant Pharmaceutical Gets Regulatory Nod for Anemia Drug in China	06-12-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Hunan Warrant Pharmaceutical Co.,Ltd

Aandelen

688799

CNE100004P73

Andere talen

Filters